The FDA approved the use of t-PA for acute stroke almost a decade ago, yet despite strong evidence that such treatment is effective, emergency physicians have not embraced it as standard of care ...

AstraZeneca to Cap Out-of-pocket Inhaler Costs in US, Following Rival Boehringer's Move Drugmaker AstraZeneca said on Monday it would cap out-of-pocket costs for its inhaled respiratory products ...